Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) (SBS) Stock Price Today
Key Stats
- $23.36BMarket Cap
- 17,617,579Volume
- UtilitiesSector
- $7.0852W High
- $4.4552W Low
- -Typical Hold Time
- $30.17BEnterprise Value
- 0.51%Div Yield
- -Trading Activity
Track Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) (SBS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) has traded between a low of $4.45 and a high of $7.08, highlighting its annual price range. Buy and sell Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares)
Sabesp provides water supply and sewage services in the Brazilian state of São Paulo. Its shares trade in Brazil as SBSP3 and in the U.S. as NYSE-listed ADSs under SBS.
Most Recent News
Sigenergy debuts AI-powered energy solutions and new partnerships at Malaysia's IGEM 2026.
At Malaysia's IGEM 2026, Sigenergy showcased its latest AI-driven energy technologies, including smart storage and inverter systems, highlighting its role in advancing sustainable energy. The company also signed MOUs with local partners Milieu and YT...

ZenaTech launches AI-powered smart safety glasses Stacklens for field technicians, with pilots in 2027.
ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...

Two biotechs and other firms priced IPOs amid cautious market, with more biotechs lined up next week.
Last week saw two biotech companies successfully price their IPOs, alongside a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company. Despite market caution limiting some IPO activity, biotechs remain activ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.